These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 21722682)

  • 1. Cellular and humoral immune effector mechanisms required for sterile protection against sporozoite challenge induced with the novel malaria vaccine candidate CelTOS.
    Bergmann-Leitner ES; Legler PM; Savranskaya T; Ockenhouse CF; Angov E
    Vaccine; 2011 Aug; 29(35):5940-9. PubMed ID: 21722682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
    Rainczuk A; Scorza T; Spithill TW; Smooker PM
    Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium berghei sporozoite challenge of vaccinated BALB/c mice leads to the induction of humoral immunity and improved function of CD8(+) memory T cells.
    Tartz S; Deschermeier C; Retzlaff S; Heussler V; Sebo P; Fleischer B; Jacobs T
    Eur J Immunol; 2013 Mar; 43(3):693-704. PubMed ID: 23229763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei.
    Bergmann-Leitner ES; Mease RM; De La Vega P; Savranskaya T; Polhemus M; Ockenhouse C; Angov E
    PLoS One; 2010 Aug; 5(8):e12294. PubMed ID: 20808868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine.
    Alves E; Salman AM; Leoratti F; Lopez-Camacho C; Viveros-Sandoval ME; Lall A; El-Turabi A; Bachmann MF; Hill AV; Janse CJ; Khan SM; Reyes-Sandoval A
    Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28179403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines.
    Espinosa DA; Vega-Rodriguez J; Flores-Garcia Y; Noe AR; Muñoz C; Coleman R; Bruck T; Haney K; Stevens A; Retallack D; Allen J; Vedvick TS; Fox CB; Reed SG; Howard RF; Salman AM; Janse CJ; Khan SM; Zavala F; Gutierrez GM
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
    Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
    J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaxfectin enhances both antibody and in vitro T cell responses to each component of a 5-gene Plasmodium falciparum plasmid DNA vaccine mixture administered at low doses.
    Sedegah M; Rogers WO; Belmonte M; Belmonte A; Banania G; Patterson NB; Rusalov D; Ferrari M; Richie TL; Doolan DL
    Vaccine; 2010 Apr; 28(17):3055-65. PubMed ID: 19879998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine.
    McCoy ME; Golden HE; Doll TA; Yang Y; Kaba SA; Zou X; Gerbasi VR; Burkhard P; Lanar DE
    Malar J; 2013 Apr; 12():136. PubMed ID: 23607541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts.
    Kariu T; Ishino T; Yano K; Chinzei Y; Yuda M
    Mol Microbiol; 2006 Mar; 59(5):1369-79. PubMed ID: 16468982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
    Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
    J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy.
    Leitner WW; Bergmann-Leitner ES; Angov E
    Malar J; 2010 May; 9():145. PubMed ID: 20507620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites.
    Leitner WW; Seguin MC; Ballou WR; Seitz JP; Schultz AM; Sheehy MJ; Lyon JA
    J Immunol; 1997 Dec; 159(12):6112-9. PubMed ID: 9550412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?
    Hoffman SL; Doolan DL
    Dev Biol (Basel); 2000; 104():121-32. PubMed ID: 11713810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
    Reyes-Sandoval A; Sridhar S; Berthoud T; Moore AC; Harty JT; Gilbert SC; Gao G; Ertl HC; Wilson JC; Hill AV
    Eur J Immunol; 2008 Mar; 38(3):732-41. PubMed ID: 18266272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid.
    Tartz S; Rüssmann H; Kamanova J; Sebo P; Sturm A; Heussler V; Fleischer B; Jacobs T
    Vaccine; 2008 Nov; 26(47):5935-43. PubMed ID: 18804138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium berghei circumsporozoite protein encapsulated in oligomannose-coated liposomes confers protection against sporozoite infection in mice.
    Terkawi MA; Kuroda Y; Fukumoto S; Tanaka S; Kojima N; Nishikawa Y
    Malar J; 2014 Nov; 13():426. PubMed ID: 25373617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of the Immunodominant CD8
    Gibbins MP; Müller K; Glover M; Liu J; Putrianti ED; Bauza K; Reyes-Sandoval A; Matuschewski K; Silvie O; Hafalla JCR
    Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32719159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.
    Sanchez GI; Sedegah M; Rogers WO; Jones TR; Sacci J; Witney A; Carucci DJ; Kumar N; Hoffman SL
    Infect Immun; 2001 Jun; 69(6):3897-905. PubMed ID: 11349057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice.
    Aly AS; Downie MJ; Mamoun CB; Kappe SH
    Cell Microbiol; 2010 Jul; 12(7):930-8. PubMed ID: 20088947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.